E178 - Why Cannabis Research Is Still Broken in Canada - Dr. Lauren Kelly
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
E178 - Why Cannabis Research Is Still Broken in Canada - Dr. Lauren Kelly
-
ナレーター：
-
著者：
Why is cannabis research so much harder than researching other medicines?
Dr. Lauren Kelly—Associate Professor at the University of Manitoba, Cannabis researcher and Trialist, CCIC President, and CMCN Co-Lead—joins Reefer MEDness to explain why cannabis clinical trials face unique barriers in Canada. Learn how Health Canada regulations, GMP vs GPP standards, product consistency challenges, and gaps in the Cannabis Act affect research, patient care, and evidence generation.
Discover why researchers often can't study the same cannabis products patients actually use, how clinical trials begin from real-world observations, and what Canada can do to become a global leader in cannabis science.
Listen now to understand the hidden challenges behind cannabis research and the future of evidence-based medical cannabis.
Dr. Lauren Kelly - LinkedIn
-University of Manitoba
Canadian Medical Cannabis Trials Network - CMCN -Website
Canadian Consortium for the Investigation of Cannabinoids - Website
Transcripts, papers and so much more at: reefermed.ca